Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ GlobeNewswire
Iterum Therapeutics Shares Soar connected FDA's Orlynvah Approval MarketWatch
After anterior rejection, Iterum nabs long-sought FDA motion for oral UTI supplier Orlynvah FiercePharma
FDA Approves Oral Sulopenem Etzadroxil and…
This communicative appeared connected news.google.com, 2024-10-25 19:45:33.053000.